These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 16760826)
41. Long-term Outcome of Low-concentration Hexyl-5-aminolaevulinate Daylight Photodynamic Therapy for Treatment of Actinic Keratoses. Neittaanmäki-Perttu N; Karppinen TT; Tani T; Snellman E; Grönroos M Acta Derm Venereol; 2017 Jan; 97(1):120-121. PubMed ID: 27304514 [No Abstract] [Full Text] [Related]
42. Radiotherapy-induced morphoea of the breast responding to photodynamic therapy. Papanikolaou M; Tsianou Z; Skellett AM; Murphy J; Millington GWM Clin Exp Dermatol; 2018 Jun; 43(4):506-508. PubMed ID: 29465162 [No Abstract] [Full Text] [Related]
43. Topical photodynamic therapy may not be effective for actinic cheilitis despite repeated treatments. Kim SK; Song HS; Kim YC Eur J Dermatol; 2013; 23(6):917-8. PubMed ID: 24201136 [No Abstract] [Full Text] [Related]
44. Treatment of refractory fingernail onychomycosis caused by nondermatophyte molds with methylaminolevulinate photodynamic therapy. Gilaberte Y; Aspiroz C; Martes MP; Alcalde V; Espinel-Ingroff A; Rezusta A J Am Acad Dermatol; 2011 Sep; 65(3):669-671. PubMed ID: 21839332 [No Abstract] [Full Text] [Related]
45. Topical photodynamic therapy with methyl aminolevulinate may be an alternative therapeutic option for the recalcitrant Malassezia folliculitis. Lee JW; Lee HI; Kim MN; Kim BJ; Chun YJ; Kim D Int J Dermatol; 2011 Apr; 50(4):488-90. PubMed ID: 21413966 [No Abstract] [Full Text] [Related]
46. [Comment on: "Photodynamic treatment of cutaneous leishmaniasis"]. Oster-Schmidt C J Dtsch Dermatol Ges; 2007 Jul; 5(7):629; author reply 629. PubMed ID: 17610616 [No Abstract] [Full Text] [Related]
47. A retrospective analysis of real-life practice of off-label photodynamic therapy using methyl aminolevulinate (MAL-PDT) in 20 Italian dermatology departments. Part 1: inflammatory and aesthetic indications. Calzavara-Pinton PG; Rossi MT; Aronson E; Sala R; Photochem Photobiol Sci; 2013 Jan; 12(1):148-57. PubMed ID: 22949035 [TBL] [Abstract][Full Text] [Related]
48. Complete remission of nodular basal cell carcinoma after combined treatment with photodynamic therapy and imiquimod 5% cream. Devirgiliis V; Panasiti V; Curzio M; Gobbi S; Rossi M; Roberti V; Calvieri S Dermatol Online J; 2008 Feb; 14(2):25. PubMed ID: 18700128 [No Abstract] [Full Text] [Related]
49. Treatment of actinic cheilitis with methyl aminolevulinate photodynamic therapy and light fractionation: a prospective study of 10 patients. Suárez-Pérez JA; López-Navarro N; Herrera-Acosta E; Aguilera J; Gallego E; Bosch R; Herrera E Eur J Dermatol; 2015; 25(6):623-4. PubMed ID: 26677980 [No Abstract] [Full Text] [Related]
50. Clinical, histological and immunohistochemical markers of resistance to methyl aminolaevulinate photodynamic therapy in Bowen disease. Gracia-Cazaña T; Salazar N; Vera-Álvarez J; Aguilera J; López-Navarro N; Herrera-Ceballos E; González S; Juarranz Á; Gilaberte Y Br J Dermatol; 2018 Feb; 178(2):e138-e140. PubMed ID: 28886215 [No Abstract] [Full Text] [Related]
52. A comparison in real clinical practice of methyl aminolevulinate photodynamic therapy and surgery for small superficial basal cell carcinoma: 3-year recurrence rates and cosmetic outcomes. Sebaratnam DF; Venugopal SS; Murrell DF J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):117-8. PubMed ID: 20456551 [No Abstract] [Full Text] [Related]
53. Photodynamic treatment of skin malignancies with aminolevulinic acid. Emphasis on anatomical observations and in vitro erythema visual assessment. Salasche SJ Dermatol Surg; 1997 Mar; 23(3):161. PubMed ID: 9145956 [No Abstract] [Full Text] [Related]
54. Topical methyl aminolevulinate photodynamic therapy for the treatment of folliculitis. Horn M; Wolf P Photodermatol Photoimmunol Photomed; 2007 Aug; 23(4):145-7. PubMed ID: 17598868 [TBL] [Abstract][Full Text] [Related]
55. A retrospective analysis of real-life practice of off-label photodynamic therapy using methyl aminolevulinate (MAL-PDT) in 20 Italian dermatology departments. Part 2: oncologic and infectious indications. Calzavara-Pinton PG; Rossi MT; Sala R; Photochem Photobiol Sci; 2013 Jan; 12(1):158-65. PubMed ID: 22949076 [TBL] [Abstract][Full Text] [Related]
57. Methyl aminolevulinate photodynamic therapy for actinic keratosis does not affect peripheral regulatory T-cell level or function. Reginato E; Gruber-Wackernagel A; Wolf P Photodermatol Photoimmunol Photomed; 2015 Sep; 31(5):274-8. PubMed ID: 25847118 [No Abstract] [Full Text] [Related]
58. The advantages of aminolevulinic acid photodynamic therapy in dermatology. Taylor EL; Brown SB J Dermatolog Treat; 2002; 13 Suppl 1():S3-11. PubMed ID: 12060511 [TBL] [Abstract][Full Text] [Related]
59. Photodynamic therapy with methyl-aminolevulinate can be useful in the management of Scytalidium infections. Aspiroz C; Fortuño-Cebamanos B; Rezusta A; Gilaberte Y Actas Dermosifiliogr; 2013 Oct; 104(8):725-7. PubMed ID: 24067255 [No Abstract] [Full Text] [Related]
60. Treatment of acne with photodynamic therapy. Bissonnette R G Ital Dermatol Venereol; 2011 Dec; 146(6):445-56. PubMed ID: 22095176 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]